Phase 2, Randomized Double-Blind Double-Dummy Placebo-Controlled Study Testing the Safety & Efficacy of Semaglutide, & the Fixed-Dose Combination of Cilofexor & Firsocostat, Alone & in Combination, in Subjects with Compensated Cirrhosis (F4) due to NASH